May 15, 2017 / 9:30 PM / 3 months ago

BRIEF-Hemispherx Biopharma announces quarterly loss per share $0.11

May 15 (Reuters) - Hemispherx Biopharma Inc

* Hemispherx Biopharma announces financial results for the three months ended March 31, 2017

* Quarterly loss per share $0.11

* Hemispherx Biopharma- Have begun to generate and can now reasonably project growing future revenues from newly manufactured lots of ampligen for 2017

* Hemispherx Biopharma - Bridge loan established on May 12 to assist in funding expenses of manufacturing Ampligen to generate revenues for 2017, 2018

* Hemispherx Biopharma Inc - Cash, cash equivalents and marketable securities were about $3.7 million at March 31, 2017 versus $5.9 million as of Dec 31, 2016 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below